Page last updated: 2024-09-03

y 590 and zaprinast

y 590 has been researched along with zaprinast in 1 studies

Compound Research Comparison

Studies
(y 590)
Trials
(y 590)
Recent Studies (post-2010)
(y 590)
Studies
(zaprinast)
Trials
(zaprinast)
Recent Studies (post-2010) (zaprinast)
500576287

Protein Interaction Comparison

ProteinTaxonomyy 590 (IC50)zaprinast (IC50)
cGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)1.9442
cGMP-specific 3',5'-cyclic phosphodiesteraseCanis lupus familiaris (dog)0.76
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A Bos taurus (cattle)2.6
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1AHomo sapiens (human)3.55
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1BBos taurus (cattle)2.6
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1BHomo sapiens (human)3.55
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1CHomo sapiens (human)3.55
cGMP-specific 3',5'-cyclic phosphodiesteraseBos taurus (cattle)0.4
G-protein coupled receptor 35Homo sapiens (human)0.8294

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bristol, JA; Cain, MH; Weishaar, RE1

Reviews

1 review(s) available for y 590 and zaprinast

ArticleYear
A new generation of phosphodiesterase inhibitors: multiple molecular forms of phosphodiesterase and the potential for drug selectivity.
    Journal of medicinal chemistry, 1985, Volume: 28, Issue:5

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Blood Platelets; Calmodulin; Cardiotonic Agents; Guinea Pigs; Humans; Hypersensitivity; In Vitro Techniques; Lung Diseases; Myocardium; Platelet Aggregation; Substrate Specificity

1985